Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Celgene pays $300m upfront for immunology start-up Delinia

Celgene pays $300m upfront for immunology start-up Delinia Star oncology drug Revlimid (lenalidomide) for blood cancer grew 16% to $1.81bn in the quarter, with follow-up Pomalyst/Innovid (pomalidomide) up 29% to $378m.

Celgene bid to push Revlimid beyond myeloma blocked again

Celgene bid to push Revlimid beyond myeloma blocked again the lymphoma market - which it has previously said could add another $1bn-$1.5bn to Revlimid’s peak sales. ... Revlimid has been a cash cow for Celgene for years and is on course to bring in around $8bn this year.

Takeda gets EU green light for oral myeloma drug

Takeda gets EU green light for oral myeloma drug drug Revlimid (lenalidomide) and dexamethasone in patients with myeloma who have been treated with at least one prior therapy.

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma Imnovid has been given the nod for the treatment of people with relapsed or refractory multiple myeloma who have undergone three previous treatments, including Celgene's Revlimid (lenalidomide) and Takeda's

Optimising Outcomes

It became critical to ensure that patients were successfully treated with REVLIMID until disease progression. ... longer-term focus on maintaining patients on REVLIMID until disease progression through better side-effect management.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics